Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 27, 2020

Linda Clark and Brad Gallagher Published on Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, recently had their “Caremark’s Bold Move to Restrict Dispensing and Access to Products on the Formulary” article published on the Pharmacy Insider blog.

“Suspect product” lists have been used for years by pharmacy benefit managers (PBMs) to target independent pharmacies and subject them to heightened scrutiny. These lists often target high margin products or other drugs that, for other unknown reasons, may be disfavored by PBMs without regard to formularies of individual plans. The lists are secret, and only “word-of-mouth” through the experiences of other network pharmacies do we learn of the targeted products or manufacturers.”

Read the full article here.

Featured Media

Alerts

Website Accessibility Lawsuits: Mizrahi Kroub LLP, Attorneys for Serial Tester Plaintiffs, Now Targeting Businesses in New York State Court

Alerts

NYS Governor Hochul Vetoes Proposed Grieving Families Act

Alerts

New Notification Requirements for Industrial Development Agencies

Alerts

HHS OCR Bulletin: Health Care Providers' Websites and Apps Could Contain HIPAA-Noncompliant Tracking Technologies

Alerts

EPA Finalizes Waters of the United States Rule

Alerts

New York State's Highest Court Rejects Untimely $2.4 Million Claim for Reformation of Insurance Policy

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out